-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
Nutrigenomic Market Competitive Analysis Highlights Growing Competition in Microbiome Testing and DNA-Based Personalized Nutrition
FMI's November 2026 competitive assessment examines six companies, emerging commercial partnerships, microbiome research investments, genetic testing capabilities, and regional expansion across the nutrigenomic industry.
Future Market Insights (FMI), a global market intelligence and consulting organization, has published its updated Competitive Analysis of Nutrigenomic Market, authored by Nandini Roy Choudhury and updated on November 19, 2026. The 250-page assessment examines the competitive positioning, company developments, product capabilities, and commercial strategies of key participants in the nutrigenomic market.
The analysis covers six companies: Viome Life Sciences, 23andMe Research Institute (TTAM Research Institute), Tiny Health, Nutrigenomix Inc., Mapmygenome India Ltd., and Xcode Life Sciences Pvt. Ltd.
The assessment identifies two major competitive approaches: microbiome-based testing and consumer genetics, alongside DNA-based personalized nutrition reports. It also examines how acquisitions, research investments, strategic partnerships, data privacy requirements, and geographic distribution influence commercial positioning.
>> Get Detailed Market Forecasts, Competitive Benchmarking, and Pricing Trends:
https://www.futuremarketinsights.com/reports/sample/rep-gb-9787
Nutrigenomic Market Structure and Competitive Landscape
The competitive landscape is characterized by companies offering different approaches to genetic and microbiome-based health assessments.
Three broad supplier categories emerge from FMI's competitive assessment:
1. Microbiome testing providers: Viome Life Sciences and Tiny Health focus on microbiome analysis, with applications spanning personalized nutrition, gut health, and research programs.
2. Consumer genetics providers: 23andMe Research Institute (TTAM Research Institute) represents the consumer genetics segment, with ownership and data privacy developments influencing its commercial positioning.
3. DNA-based personalized nutrition providers: Nutrigenomix Inc., Mapmygenome India Ltd., and Xcode Life Sciences Pvt. Ltd. provide genetic testing and nutrition-related reporting services through practitioner networks, accredited laboratories, and uploaded DNA data.
Verified Company and Product Developments
FMI's competitive assessment identifies the following company developments and commercial activities:
· Viome Life Sciences – Japan market entry (September 2026): Viome and Ezaki Glico launched a gut mRNA health tracker in Japan. The partnership illustrates the role of established regional food companies in expanding access to microbiome-related services.
· Viome Life Sciences – Acquisition (October 2026): Viome acquired Solaria Bio, connecting its testing capabilities with clinically studied medical foods that are sold without requiring a test.
· 23andMe Research Institute (TTAM Research Institute) – Ownership transition (June 27, 2025): TTAM Research Institute received court approval to acquire 23andMe's assets for USD 305 million. The transaction placed the consumer genetics business under nonprofit ownership with additional privacy terms.
· Tiny Health – Research investment (September 29, 2026): Tiny Health announced a USD 5 million Microbiome Research Program, providing researchers and clinicians access to its testing and data for interventional studies.
· Nutrigenomix Inc. – Practitioner distribution: The company reports a network of more than 12,000 practitioners across 95 countries, supporting the distribution of genetic tests for personalized nutrition.
· Mapmygenome India Ltd. – Laboratory capabilities: The company offers at-home DNA, gut, and epigenome testing kits processed in CAP- and NABL-accredited laboratories.
· Xcode Life Sciences Pvt. Ltd. – DNA report services: The company offers 11 reports generated from uploaded raw DNA data and does not ship physical testing kits.
Key Industry Questions: Nutrigenomic Market
Q1. What is the competitive structure of the nutrigenomic market?
The competitive landscape includes microbiome testing providers, consumer genetics companies, and DNA-based personalized nutrition providers. Viome Life Sciences and Tiny Health focus on microbiome testing, 23andMe Research Institute operates in consumer genetics, while Nutrigenomix, Mapmygenome, and Xcode Life Sciences focus on DNA-based diet reports.
Q2. Which verified company developments are influencing competition?
Key developments include Viome's September 2026 partnership with Ezaki Glico in Japan, its October 2026 acquisition of Solaria Bio, Tiny Health's USD 5 million Microbiome Research Program announced on September 29, 2026, and the June 27, 2025 court-approved USD 305 million acquisition of 23andMe assets by TTAM Research Institute.
Q3. How does regional distribution influence nutrigenomic market competition?
Regional partnerships and laboratory infrastructure support geographic reach. Viome's partnership with Ezaki Glico provides a Japan market entry example, while Mapmygenome serves Indian customers through its CAP- and NABL-accredited laboratory operations. Nutrigenomix reports a practitioner network spanning 95 countries.
Q4. What proprietary information is available in FMI's nutrigenomic competitive analysis?
FMI's 250-page competitive assessment covers company positioning, verified developments, commercial implications, and competitive benchmarking. Its research methodology incorporates primary interviews, secondary literature analysis, and top-down data triangulation to assess market size, segment shares, and competitive positioning.
Research Methodology
Future Market Insights conducted its nutrigenomic market assessment using a combination of:
· Primary research: Interviews to gather industry perspectives and assess competitive positioning.
· Secondary research: Literature analysis to examine company activities, industry developments, and market dynamics.
· Top-down data triangulation: An analytical approach used to validate market size, segment shares, and competitive positioning.
Verification and evidence disclosure: The published competitive analysis identifies company developments and their respective dates. However, the source page does not separately document a mandatory verification protocol involving regulatory approvals, company announcements, product documentation, and public filings. Accordingly, those procedures cannot be represented as confirmed FMI methodology for this particular study.
Explore the complete research report:
https://www.futuremarketinsights.com/reports/nutrigenomic-market
Explore More Research Reports by FMI
Blockchain Food Traceability Market -
https://www.futuremarketinsights.com/reports/blockchain-food-traceability-market
Food Technology Market -
https://www.futuremarketinsights.com/reports/food-technology-market
About Future Market Insights (FMI)
Future Market Insights, Inc. is an ESOMAR-certified market research and consulting organization registered in the State of Delaware, United States. FMI provides market intelligence, competitive assessments, industry analysis, and strategic research to businesses across global industries.
Its research combines primary interviews, secondary research, and analytical validation to support commercial assessments, market benchmarking, and research licensing requirements.
- Art
- Causes
- Crafts
- Dance
- Drinks
- Film
- Fitness
- Food
- Игры
- Gardening
- Health
- Главная
- Literature
- Music
- Networking
- Другое
- Party
- Religion
- Shopping
- Sports
- Theater
- Wellness